Re: Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).
0/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 44.0%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
APA
Petranović Ovčariček P, Tuncel M, et al. (2025). Re: Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).. European journal of nuclear medicine and molecular imaging, 52(12), 4364-4367. https://doi.org/10.1007/s00259-025-07367-z
MLA
Petranović Ovčariček P, et al.. "Re: Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).." European journal of nuclear medicine and molecular imaging, vol. 52, no. 12, 2025, pp. 4364-4367.
PMID
40439711 ↗
같은 제1저자의 인용 많은 논문 (5)
- Marine-Lenhart syndrome: why nuclear medicine imaging remains essential for diagnosis and treatment.
- The 2025 ATA guidelines for differentiated thyroid Cancer - Ten years of professional debate and measured progress.
- Radioiodine-refractory thyroid cancer-is it time to change the definition in light of novel redifferentiation therapies?
- Clinical Advances in Thyroid Disease Assessment and Management.
- Thyroid Ultrasonography: Much Ado About Nothing? A Provocative Analysis.